James Cancer Hospital & Solove Research Institute is a clinical research site located in Columbus, Ohio, United States 43210.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
James Cancer Hospital & Solove Research Institute has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Low-grade Serous Ovarian Cancer, Low-grade Serous Fallopian Tube Cancer, Low-grade Serous Peritoneal Cancer.
Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
James Cancer Hospital & Solove Research Institute has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
James Cancer Hospital & Solove Research Institute has 2 clinical trials on record, with 1 currently active. Their work covers Low-grade Serous Ovarian Cancer, Low-grade Serous Fallopian Tube Cancer, Low-grade Serous Peritoneal Cancer.
James Cancer Hospital & Solove Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.